| : : Quality
Policy |
| At Murli
Krishna Pharma, we believe in building quality
systems from the grassroot level. If one has
to assure quality, proper systems have to
be implemented right from the receipt of raw
material through well defined storage for
incoming raw material and packing materials
through elaborate and well defined process,
through quality checks at every stage right
upto packing and despatching. Well-defined
systems supported by extensive documentation
ensures consistent product quality with total
traceability of the manufactured batch. |
 |
|
| Our quality policy not
only extends through in house operations but also
extends to vendors who are our suppliers for Active
Product Ingredients and Execipients. The quality
Assurance department assures quality through a well
designed quality management programme. The programme
begins with the following: |
 |
 |
Documentation
related to product development. |
|
Assessment
of prototype. |
|
Evaluation
of prototype in terms of quality as
well as cost effectiveness. |
|
Systematic
scale and transfer of technology in
production. |
|
Through
well defined testing procedures for
incoming raw material and packaging
materials. |
|
Through
evaluation of production stages wide
in-process quality control test. |
|
Through
testing of final product. |
|
|
We have well defined validation master plan, which
ensures smooth functioning of machines and hence
the process. We also have a well-defined stability
protocol and programme that ensures the velocity
of the claimed shelf life. We have a LAN System
that facilitates a bi-directional communications
with the key departments. This ensures efficient
data management. This computer system is designed
using validated software and confirms to 21 CFR
Part level guidelines. |
No quality
policy can be complete if it is not packed
up by the trained manpower. We have cogently
devised training programme which is not only
aimed at imparting awareness and training
right from worker level to management level
too.
We take endeavors not only to build quality
product but also to develop quality people
and the systems that go a long way to assure
a top quality product. |
 |
|
| Research and
Development |
Current trend in formulations
is heading towards development of safer and more
effective drug delivery systems. This system is
based on well-designed intelligently defined granulation
technique followed by quoting using proper polymer
matrix.
We at Murli Krishna Pharma wanted to offer a ready
solution for the end user so that the end user has
a semi finished formulation in bulk form, which
is ready for use. This semi finished formulation
would be used for solid as well as liquid dosage
form.
We take pride in devising semi-finished formulations
with thoughtful selection of matrix and congent
selection of polymers. The matrix is selected based
on the physico-chemical properties of the drug molecule.
One of the approaches through product development
is to devise a process using a non infringing execipients.
The another highlight of our product development
programme that we do the development using aqueous
base and we avoid the use of organic solvents thereby
toxic effects that arise from the use of organic
solvents are eliminated.
Our R&D has devised a unique and innovative
techniques to render water soluble drugs to be layered
using aqueous media. The innovative approach of
R & D has ensured product quality that confirms
to strictest analytical specifications. |
| top |
| This
website is not and should not constitute an offer
for sale in territories where it is not permitted
by Patent Law. |
